Difference between revisions of "Zhengli Shi"
(Tidy research) |
|||
| Line 31: | Line 31: | ||
==Research== | ==Research== | ||
| − | Shi is the director of the Center for Emerging Infectious Diseases of the [[Wuhan Institute of Virology]]. Her research focuses on viral pathogen discovery through traditional and high-throughput sequencing techniques. She has been studying the wildlife-borne viral pathogens, particularly bat-borne viruses since 2004. Her group has discovered diverse novel viruses/virus antibodies in bats, including [[SARS]]-like coronaviruses, adenoviruses, adeno-associated viruses, circoviruses, paramyxoviruses and filoviruses in China. | + | Shi is the director of the Center for Emerging Infectious Diseases of the [[Wuhan Institute of Virology]]. Her research focuses on viral pathogen discovery through traditional and high-throughput sequencing techniques. She has been studying the wildlife-borne viral pathogens, particularly bat-borne viruses since 2004. Her group has discovered diverse novel viruses/virus antibodies in bats, including [[SARS]]-like coronaviruses, adenoviruses, adeno-associated viruses, circoviruses, paramyxoviruses and filoviruses in China. With her international collaborators she has provided evidence that bats are natural reservoirs of SARS-CoV. She has coauthored over 130 publications on viral pathogen identification, diagnosis and epidemiology.<ref>[https://www.ws-virology.org/dt_team/zhengli-shi/ World Society for Virology] - profile 22 March 2020</ref> |
==Opinions on Covid-19== | ==Opinions on Covid-19== | ||
Revision as of 18:57, 31 March 2020
 Zhengli Shi    (Scientist) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | ||||||||||||
| Born | 26 May 1964 Xixia County, Henan, China | |||||||||||
| Nationality | Chinese | |||||||||||
| Alma mater | Montpellier 2 University | |||||||||||
| Interests | • coronaviruses • SARS • HIV | |||||||||||
| Interest of | Eric Donaldson | |||||||||||
Director of the Center for Emerging Infectious Diseases of the Wuhan Institute of Virology, an active researcher
| ||||||||||||
Professor Zhengli Shi is a Chinese virologist. She was the director of the Center for Emerging Infectious Diseases of the Wuhan Institute of Virology at the time of the COVID-19 outbreak in late 2019 in Wuhan.
Contents
Background
Zhengli Shi was born in Chine in 1964. She graduated from Wuhan University in 1987. She received her master's degree from the Chinese Academy of Sciences' Wuhan Institute of Virology in 1990. She did a Ph.D at Montpellier 2 University, France, from 1996 to 2000.
Research
Shi is the director of the Center for Emerging Infectious Diseases of the Wuhan Institute of Virology. Her research focuses on viral pathogen discovery through traditional and high-throughput sequencing techniques. She has been studying the wildlife-borne viral pathogens, particularly bat-borne viruses since 2004. Her group has discovered diverse novel viruses/virus antibodies in bats, including SARS-like coronaviruses, adenoviruses, adeno-associated viruses, circoviruses, paramyxoviruses and filoviruses in China. With her international collaborators she has provided evidence that bats are natural reservoirs of SARS-CoV. She has coauthored over 130 publications on viral pathogen identification, diagnosis and epidemiology.[1]
Opinions on Covid-19
“The novel 2019 coronavirus is nature punishing the human race for keeping uncivilized living habits. I, Shi Zhengli, swear on my life that it has nothing to do with our laboratory. I advise those who believe and spread rumors from harmful media sources, as well as those who believe the unreliable so-called academic analysis of Indian scholars, to shut their stinking mouths.”
Shi Zhengli (February 2020) [2]
Publications
- 2015 - Nature Medicine - A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence - With co-authors Vineet Menachery, Boyd Yount Jr, Kari Debbink, Sudhakar Agnihothram, Lisa Gralinski, Jessica Plante, Rachel Graham, Trevor Scobey, Xing-Yi Ge, Eric Donaldson, Scott Randell, Antonio Lanzavecchia, Wayne Marasco and Ralph Baric. It reported that "in vivo experiments demonstrate replication of the chimeric virus in mouse lung with notable pathogenesis."[3]
- 2007 - Journal of Virology - Difference in Receptor Usage between Severe Acute Respiratory Syndrome (SARS) Coronavirus and SARS-Like Coronavirus of Bat Origin, a paper with co-authors Wuze Ren, Xiuxia Qu, Wendong Li, Zhenggang Han, Meng Yu, Peng Zhou, Shu-Yi Zhang, Lin-Fa Wang, Hongkui Deng on development of a SARS/HIV hybrid. Shi was corresponding author.[4]
Related Document
| Title | Type | Publication date | Author(s) | Description |
|---|---|---|---|---|
| Document:Logistical and Technical Exploration into the Origins of the COVID-19 virus | report | 31 January 2020 | Jonathan Jay Couey | Report of a thorough investigation into the origins of the virus that caused the pandemic. Whilst the author is circumspect, the evidence presented points clearly to the virus being the product of laboratory engineering. |
References
- ↑ World Society for Virology - profile 22 March 2020
- ↑ https://www.nature.com/articles/nm.3985
- ↑ https://jvi.asm.org/content/82/4/1899
